$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Use of L-arginine in the treatment of hypertension and other vascular disorders 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/195
출원번호 US-0873892 (1992-04-24)
발명자 / 주소
  • Levere Richard D. (5 Seymour Pl. W. Armonk NY 10504) Abraham Nader G. (143 Charter Cir. Ossining NY 10562) Schwartzman Michel L. (415 Old Country Rd. Elmsford NY 10523) Martasek Pavel (60 Hillcrest R
인용정보 피인용 횟수 : 65  인용 특허 : 0

초록

A method for treating a high vascular resistance disorder in a mammal by administering to a mammalian organism in need of such treatment a sufficient amount of L-arginine or pharmaceutically acceptable salt thereof to treat a high vascular resistance disorder. The L-arginine is typically administere

대표청구항

A method for treating a high vascular resistance disorder in a mammal, said method comprising administering to a mammalian organism in need of such treatment a sufficient amount of L-arginine or pharmaceutically acceptable salt thereof to treat a high vascular resistance disorder.

이 특허를 인용한 특허 (65)

  1. Juturu, Vijaya; Komorowski, James R., Arginine silicate inositol complex and use thereof.
  2. Andrew Blitzer ; Terry Pretorius, Athletic patch.
  3. Blitzer, Andrew; Pretorius, Terry, Athletic patch.
  4. Fossel, Eric T., Beneficial effects of increasing local blood flow.
  5. Kealey, Kirk S.; Snyder, Rodney M.; Romanczyk, Jr., Leo J.; Geyer, Hans M.; Myers, Mary E.; Whitacre, Eric J.; Hammerstone, Jr., John F.; Schmitz, Harold H., Chocolates and chocolate liquor having an enhanced polyphenol content.
  6. Baichwal, Anand R.; Woodcook, Paul; Higgins, Raymond; Cobb, Jaclyn, Chronotherapeutic dosage forms and methods of treatment using chronotherapy.
  7. Don C. Pearson ; Kenneth T. Richardson, Clinical uses for L-arginine ascorbate and various metalloarginate complexes.
  8. Butler, Terri L.; St. Cyr, John; Johnson, Clarence A., Compositions and methods for improving cardiovascular function.
  9. Rothbard, Jonathan B.; McGrane, Paul L.; Engleman, Edgar G.; Fathman, C. Garrison; Kreider, Erik, Compositions and methods for treating diseases.
  10. Byrd, Edward A., Controlled release arginine α-ketoglutarate.
  11. Baichwal, Anand R.; Woodcock, Paul; Higgins, Raymond; Cobb, Jaclyn, Delayed release dosage forms.
  12. Fossel, Eric T., Delivery of ibuprofen and other compounds.
  13. Fossel, Eric T., Delivery of ibuprofen and other compounds.
  14. Fossel, Eric T., Delivery of ibuprofen and other compounds.
  15. Cooke John P. ; Dzau Victor J. ; Gibbons Gary H., Enhancement of vascular function by modulation of endogenous nitric oxide production or activity.
  16. Cooke, John P.; Dzau, Victor J.; Gibbons, Gary H., Enhancement of vascular function by modulation of endogenous nitric oxide production or activity.
  17. Cooke,John P., Enhancement of vascular function by modulation of endogenous nitric oxide production or activity.
  18. Chevaux, Kati A.; Schmitz, Harold H.; Romanczyk, Jr., Leo J., Food products containing polyphenol(s) and L-arginine to stimulate nitric oxide.
  19. Wilks, Angela; MacKerrel, Jr., Alexander; Furci, Lena; Lopes, Pedro, Heme oxygenase inhibitors, screening methods for heme oxygenase inhibitors and methods of use of heme oxygenase inhibitors for antimicrobial therapy.
  20. Wideman ; Jr. Robert F. ; Bottje Walter G., In ovo use of L-arginine and salts thereof in the prevention and/or treatment of pulmonary hypertension syndrome in avians.
  21. Moskowitz, Michael A.; Liao, James K.; Ron, Eyal S.; Omstead, Mary Nallin, Increasing cerebral bioavailability of drugs.
  22. Trant,Aileen Sontag, Method and composition for improving fertility health in female and male animals and humans.
  23. Trant,Aileen Sontag, Method and composition for improving male fertility health.
  24. Hank C. K. Wuh ; Aileen S. Trant ; Denny W. Kwock, Method and composition for improving sexual fitness.
  25. Wuh, Hank C. K.; Trant, Aileen S., Method and composition for improving sexual fitness.
  26. Levere Richard D. ; Abraham Nadar G. ; Schwartzman Michal L. ; Dunn Michael W., Method for treating non-ocular epithelial disorders via increasing heme oxygenase levels and/or decreasing levels of ara.
  27. Lawson Charles A. ; Pinsky David J. ; Smerling Arthur ; Stern David M., Method of inducing vasorelaxation to treat pulmonary hypertension.
  28. Lawson Charles A. ; Pinsky David J. ; Smerling Arthur ; Stern David M., Method of inducing vasorelaxation to treat pulmonary hypertension.
  29. Van Leeuwen Paulus Aloisius Marie,NLX ; Houdijk Alexander Petrus Jacobus,NLX, Method of treating disorders of the animal or human body by administering amino acids.
  30. Summar, Marshall L.; Barr, Frederick E.; Thompson, Reid Carleton, Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage.
  31. Busetti Cesare,ITX ; Crimella Tiziano,ITX, Methods for treating early morning pathologies.
  32. Busetti,Cesare; Crimella,Tiziano, Methods for treating early morning pathologies.
  33. Romanczyk, Jr., Leo J.; Schmitz, Harold H., Methods of manufacture and combination compositions.
  34. Messadek, Jallal, Modulation of nitric oxide synthases by betaines.
  35. Sarama, Robert Joseph; Niehoff, Raymond Louis, Palatable arginine compounds and uses thereof for cardiovascular health.
  36. Gross, Steven S.; Jones, Caroline L., Pharmacotherapy for vascular dysfunction associated with deficient nitric oxide bioactivity.
  37. Chevaux, Kati A.; Schmitz, Harold H.; Romanczyk, Leo J., Products containing polyphenol(s) and L-arginine.
  38. Chevaux, Kati A.; Schmitz, Harold H.; Romanczyk, Leo J., Products containing polyphenol(s) and L-arginine and methods of use thereof.
  39. Jao, Frank; Wong, Patrick S. -L.; Huynh, Hoa T.; Mc Chesney, Kathy; Wat, Pamela K., System for delaying drug delivery up to seven hours.
  40. Fossel, Eric T., Systems and methods for treatment of allergies and other indications.
  41. Summar, Marshall L.; Christman, Brian W.; Barr, Frederick E., Therapeutic methods employing nitric oxide precursors.
  42. Summar, Marshall L.; Christman, Brian W.; Barr, Frederick E., Therapeutic methods employing nitric oxide precursors.
  43. Summar, Marshall L.; Christman, Brian W.; Barr, Frederick E., Therapeutic methods employing nitric oxide precursors.
  44. Summar, Marshall L.; Christman, Brian W., Therapeutic methods relating to human carbamyl phosphate synthetase I polymorphism.
  45. Messadek, Jallal, Therapeutic treatment.
  46. Fossel, Eric T., Topical composition containing ibuprofen.
  47. Fossel, Eric T., Topical composition containing naproxen.
  48. Barone, Jr.,Frank V.; Jacobsen,Christopher; Chumenko,Kirill, Topical compositions for enhancing sexual responsiveness.
  49. Fossel, Eric T., Topical delivery of L-arginine to cause beneficial effects.
  50. Hechtman Herbert B. (Chestnut Hill MA), Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointes.
  51. Fossel, Eric Thor, Transdermal delivery of beneficial substances effected by a hostile biophysical environment.
  52. Morris, Claudia R., Treatment and diagnosis of conditions associated with elevated arginase activity.
  53. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  54. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  55. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  56. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  57. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  58. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  59. Fossel, Eric T., Treatment of erectile dysfunction and other indications.
  60. Garfield Robert E. ; Chwalisz Krzysztof,DEX ; Bukowski Radoslaw,DEX ; Yallampal Li Chandra, Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substra.
  61. Garfield, Robert E.; Chwalisz, Krzysztof; Bukowski, Radoslaw; Yallampalli, Chandra, Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor.
  62. Garfield Robert E. ; Chwalisz Krzysztof,DEX ; Bukowski Radoslaw,DEX ; Yallampalli Chandra, Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor or a nitric oxide inh.
  63. Garfield Robert E. ; Chwalisz Krzysztof,DEX ; Bukowski Radoslaw,DEX ; Yallampalli Chandra, Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide in.
  64. Cooke John P. ; Dzau Victor J. ; Gibbons Gary H., Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity.
  65. Wideman ; Jr. Robert F. ; Bottje Walter G. ; Kidd Michael T., Use of L-arginine and salts thereof in drinking water for the prevention and/or treatment of pulmonary hypertension synd.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로